240 related articles for article (PubMed ID: 28481868)
21. The peptidyl prolyl isomerase, PIN1 induces angiogenesis through direct interaction with HIF-2α.
Choi MA; Saeidi S; Han HJ; Kim SJ; Kwon N; Kim DH; Min SH; Choi BY; Surh YJ
Biochem Biophys Res Commun; 2020 Dec; 533(4):995-1003. PubMed ID: 33012513
[TBL] [Abstract][Full Text] [Related]
22. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y
Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806
[TBL] [Abstract][Full Text] [Related]
23. SUPT5H Post-Transcriptional Silencing Modulates PIN1 Expression, Inhibits Tumorigenicity, and Induces Apoptosis of Human Breast Cancer Cells.
Lone BA; Ahmad F; Karna SKL; Pokharel YR
Cell Physiol Biochem; 2020 Sep; 54(5):928-946. PubMed ID: 32961044
[TBL] [Abstract][Full Text] [Related]
24. Prolyl isomerase Pin1 enhances osteoblast differentiation through Runx2 regulation.
Lee SH; Choi YH; Kim YJ; Choi HS; Yeo CY; Lee KY
FEBS Lett; 2013 Nov; 587(22):3640-7. PubMed ID: 24113655
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
[TBL] [Abstract][Full Text] [Related]
26. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
27. Prolyl isomerase Pin1 regulates the osteogenic activity of Osterix.
Lee SH; Jeong HM; Han Y; Cheong H; Kang BY; Lee KY
Mol Cell Endocrinol; 2015 Jan; 400():32-40. PubMed ID: 25463757
[TBL] [Abstract][Full Text] [Related]
28. Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16.
Nakatsu Y; Matsunaga Y; Yamamotoya T; Ueda K; Inoue MK; Mizuno Y; Nakanishi M; Sano T; Yamawaki Y; Kushiyama A; Sakoda H; Fujishiro M; Ryo A; Ono H; Minamino T; Takahashi SI; Ohno H; Yoneda M; Takahashi K; Ishihara H; Katagiri H; Nishimura F; Kanematsu T; Yamada T; Asano T
Cell Rep; 2019 Mar; 26(12):3221-3230.e3. PubMed ID: 30893596
[TBL] [Abstract][Full Text] [Related]
29. The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion.
Nakatsu Y; Mori K; Matsunaga Y; Yamamotoya T; Ueda K; Inoue Y; Mitsuzaki-Miyoshi K; Sakoda H; Fujishiro M; Yamaguchi S; Kushiyama A; Ono H; Ishihara H; Asano T
J Biol Chem; 2017 Jul; 292(28):11886-11895. PubMed ID: 28566287
[TBL] [Abstract][Full Text] [Related]
30. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
[TBL] [Abstract][Full Text] [Related]
31. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
[TBL] [Abstract][Full Text] [Related]
32. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
Cho JH; Chae JI; Shim JH
Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
[TBL] [Abstract][Full Text] [Related]
33. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
[TBL] [Abstract][Full Text] [Related]
34. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
35. Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.
Legname G; Virgilio T; Bistaffa E; De Luca CMG; Catania M; Zago P; Isopi E; Campagnani I; Tagliavini F; Giaccone G; Moda F
Prion; 2018 Mar; 12(2):127-137. PubMed ID: 29676205
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
37. Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization.
Werwein E; Cibis H; Hess D; Klempnauer KH
Nucleic Acids Res; 2019 Jan; 47(1):103-121. PubMed ID: 30321399
[TBL] [Abstract][Full Text] [Related]
38. MYC protein stability is negatively regulated by BRD4.
Devaiah BN; Mu J; Akman B; Uppal S; Weissman JD; Cheng D; Baranello L; Nie Z; Levens D; Singer DS
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13457-13467. PubMed ID: 32482868
[TBL] [Abstract][Full Text] [Related]
39. Pin1 enhances adipocyte differentiation by positively regulating the transcriptional activity of PPARγ.
Han Y; Lee SH; Bahn M; Yeo CY; Lee KY
Mol Cell Endocrinol; 2016 Nov; 436():150-8. PubMed ID: 27475846
[TBL] [Abstract][Full Text] [Related]
40. Pin1 and JNK1 cooperatively modulate TAp63γ.
Fan X; He W; Hu K; Chen H; Chen L; Fan S; Li C
FEBS Open Bio; 2021 Mar; 11(3):890-897. PubMed ID: 33548094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
